5AM Opportunities I (GP), LLC
Insider CIK 1790778 · IMPL 10% owner · SCPH 10% owner · ELVN 10% owner · IDYA 10% owner · TRDA 10% owner · AKUS 10% owner · RLYB 10% owner · CABA 10% owner · APRE 10% owner · VOR 10% owner · PEAR 10% owner · CINC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-07 | 2026-08-10 | 52,317 | $6.85 | $358.4K | 2,783,781 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-07 | 2026-08-10 | 52,317 | $6.85 | $358.4K | 2,783,781 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-06 | 2026-08-10 | 10,494 | $7.00 | $73.5K | 2,836,098 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-06 | 2026-08-10 | 10,494 | $7.00 | $73.5K | 2,836,098 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-07-31 | 2026-08-03 | 1,718 | $6.85 | $11.8K | 2,846,592 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-07-31 | 2026-08-03 | 1,718 | $6.85 | $11.8K | 2,846,592 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-07-30 | 2026-08-03 | 114,756 | $6.93 | $795.3K | 2,848,310 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-07-30 | 2026-08-03 | 114,756 | $6.93 | $795.3K | 2,848,310 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-11-14 | 2025-11-18 | 200,000 | $8.80 | $1.76M | 2,963,066 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-07-09 | 2025-07-11 | 6,935 | $7.50 | $52.0K | 1,093,313 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-07-09 | 2025-07-11 | 20,065 | $7.50 | $150.5K | 3,163,066 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-07-01 | 2025-07-01 | 18,578 | $7.12 | $132.3K | 3,183,131 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-07-01 | 2025-07-01 | 6,422 | $7.12 | $45.7K | 1,100,248 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-06-30 | 2025-07-01 | 6,422 | $6.81 | $43.7K | 1,106,670 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-06-30 | 2025-07-01 | 18,578 | $6.81 | $126.5K | 3,201,709 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-06-27 | 2025-07-01 | 19,265 | $6.91 | $133.1K | 1,113,092 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2025-06-27 | 2025-07-01 | 55,735 | $6.91 | $385.1K | 3,220,287 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-02-14 | 2024-02-16 | 688,358 | $14.90 | $10.26M | 3,200,634 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-02-14 | 2024-02-16 | 136,642 | $14.90 | $2.04M | 635,341 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-31 | 2024-02-02 | 82,813 | $15.00 | $1.24M | 771,983 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-31 | 2024-02-02 | 417,187 | $15.00 | $6.26M | 3,888,992 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-09-26 | 2023-09-28 | 32,711 | $15.00 | $490.7K | 854,796 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-09-26 | 2023-09-28 | 164,789 | $15.00 | $2.47M | 4,306,179 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-08-24 | 2023-08-28 | 367,124 | $16.00 | $5.87M | 4,470,968 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-08-24 | 2023-08-28 | 72,876 | $16.00 | $1.17M | 887,507 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2023-04-10 | 2023-04-12 | 534,855 | $0.12 | $64.2K | 0 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2023-04-10 | 2023-04-12 | 3,172,769 | $0.12 | $380.7K | 200,000 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2023-04-10 | 2023-04-12 | 12,836,489 | $0.12 | $1.54M | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-28 | 496,323 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-28 | 3,953,990 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | U Tender | 2023-02-24 | 2023-02-28 | 487,333 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | U Tender | 2022-11-30 | 2022-12-02 | 982,453 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | U Tender | 2022-11-30 | 2022-12-02 | 3,153,333 | — | $0 | 0 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-11-15 | 2022-11-15 | 2,551 | $2.52 | $6.4K | 534,855 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-11-15 | 2022-11-15 | 61,222 | $2.52 | $154.3K | 12,836,489 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-11-14 | 2022-11-15 | 11,643 | $2.79 | $32.5K | 12,897,711 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-11-14 | 2022-11-15 | 485 | $2.79 | $1.4K | 537,406 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-11-11 | 2022-11-15 | 28,205 | $3.19 | $90.0K | 12,909,354 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-11-11 | 2022-11-15 | 1,175 | $3.19 | $3.7K | 537,891 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-02 | 423 | $2.72 | $1.2K | 539,066 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-11-02 | 2022-11-02 | 10,155 | $2.72 | $27.6K | 12,937,559 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 59 | $2.80 | $165 | 539,489 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-11-01 | 2022-11-02 | 1,408 | $2.80 | $3.9K | 12,947,714 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 40,477 | $2.78 | $112.5K | 12,949,122 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-10-31 | 2022-11-02 | 1,687 | $2.78 | $4.7K | 539,548 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-10-10 | 2022-10-11 | 19,017 | $4.09 | $77.8K | 92,983 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-10-10 | 2022-10-11 | 87,036 | $4.09 | $356.0K | 410,268 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-10-10 | 2022-10-11 | 456,413 | $4.09 | $1.87M | 2,231,601 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-10-06 | 2022-10-11 | 30,457 | $5.02 | $152.9K | 2,688,014 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-10-06 | 2022-10-11 | 1,269 | $5.02 | $6.4K | 112,000 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-10-06 | 2022-10-11 | 5,808 | $5.02 | $29.2K | 497,304 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-09-16 | 2022-09-16 | 337 | $1.75 | $590 | 12,989,599 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-09-16 | 2022-09-16 | 14 | $1.75 | $25 | 541,235 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-09-15 | 2022-09-16 | 261,840 | $1.81 | $473.9K | 12,989,936 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-09-15 | 2022-09-16 | 10,910 | $1.81 | $19.7K | 541,249 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-09-14 | 2022-09-16 | 273,664 | $1.94 | $530.9K | 13,251,776 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-09-14 | 2022-09-16 | 11,403 | $1.94 | $22.1K | 552,159 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-09-08 | 2022-09-08 | 12,173 | $1.81 | $22.0K | 563,562 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-09-08 | 2022-09-08 | 292,149 | $1.81 | $528.8K | 13,525,440 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-09-07 | 2022-09-08 | 6,793 | $4.75 | $32.3K | 113,269 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-09-07 | 2022-09-08 | 163,034 | $4.75 | $774.4K | 2,718,471 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-09-07 | 2022-09-08 | 30,173 | $4.75 | $143.3K | 503,112 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-09-07 | 2022-09-08 | 148,337 | $1.92 | $284.8K | 13,817,589 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-09-07 | 2022-09-08 | 6,181 | $1.92 | $11.9K | 575,735 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-09-06 | 2022-09-08 | 4,016 | $5.52 | $22.2K | 533,285 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-09-06 | 2022-09-08 | 21,702 | $5.52 | $119.8K | 2,881,505 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-09-06 | 2022-09-08 | 904 | $5.52 | $5.0K | 120,062 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-09-06 | 2022-09-08 | 298,714 | $2.36 | $705.0K | 13,965,926 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-09-06 | 2022-09-08 | 12,446 | $2.36 | $29.4K | 581,916 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-08-18 | 2022-08-18 | 8,910 | $1.55 | $13.8K | 594,362 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-08-18 | 2022-08-18 | 213,851 | $1.55 | $331.5K | 14,264,640 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-08-17 | 2022-08-18 | 9,674 | $1.71 | $16.5K | 14,478,491 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-08-17 | 2022-08-18 | 403 | $1.71 | $689 | 603,272 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-08-16 | 2022-08-18 | 160,476 | $1.78 | $285.6K | 14,488,165 | SEC↗ |
| PEAR Pear Therapeutics, Inc. | S Sale | 2022-08-16 | 2022-08-18 | 6,686 | $1.78 | $11.9K | 603,675 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-08-15 | 2022-08-17 | 112,667 | $30.00 | $3.38M | 3,953,990 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-08-15 | 2022-08-17 | 487,333 | $30.00 | $14.62M | 487,333 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-06-03 | 2022-06-07 | 99,671 | $12.50 | $1.25M | 2,478,969 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-06-03 | 2022-06-07 | 50,329 | $12.50 | $629.1K | 1,251,755 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-05-23 | 2022-05-25 | 66,447 | $13.00 | $863.8K | 2,578,640 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-05-23 | 2022-05-25 | 33,553 | $13.00 | $436.2K | 1,302,084 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-04-11 | 2022-04-13 | 40,733 | $5.00 | $203.7K | 537,301 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-04-11 | 2022-04-13 | 220,096 | $5.00 | $1.10M | 2,903,207 | SEC↗ |
| SCPH scPharmaceuticals Inc. | S Sale | 2022-04-11 | 2022-04-13 | 9,171 | $5.00 | $45.9K | 120,966 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-02-08 | 2022-02-10 | 70,461 | $13.05 | $919.5K | 1,335,637 | SEC↗ |
| RLYB Rallybio Corp | S Sale | 2022-02-08 | 2022-02-10 | 139,539 | $13.05 | $1.82M | 2,645,087 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 625,000 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 2,525,000 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-13 | 9,999,999 | — | $0 | 0 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-01-11 | 2022-01-13 | 312,500 | $16.00 | $5.00M | 496,323 | SEC↗ |
| CINC CinCor Pharma, Inc. | P Buy | 2022-01-11 | 2022-01-13 | 157,500 | $16.00 | $2.52M | 3,841,323 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion | 2022-01-11 | 2022-01-13 | 183,823 | — | $0 | 183,823 | SEC↗ |
| CINC CinCor Pharma, Inc. | C Conversion | 2022-01-11 | 2022-01-13 | 3,683,823 | — | $0 | 3,683,823 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2021-11-16 | 2021-11-18 | 238,870 | $15.30 | $3.65M | 4,595,089 | SEC↗ |
| VOR Vor Biopharma Inc. | S Sale | 2021-11-16 | 2021-11-18 | 91,836 | $15.30 | $1.41M | 1,766,634 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 2,305,473 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 17,161,644 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 4,082,613 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 1,841,620 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 2,302,026 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | P Buy | 2021-11-02 | 2021-11-04 | 250,000 | $20.00 | $5.00M | 1,132,357 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 318,140 | — | $0 | 882,357 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 254,512 | — | $0 | 3,276,022 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 564,217 | — | $0 | 564,217 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 2,371,739 | — | $0 | 3,021,510 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 318,616 | — | $0 | 649,771 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-11-01 | 2021-11-03 | 36,544 | $13.00 | $475.1K | 333,144 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-11-01 | 2021-11-03 | 258,456 | $13.00 | $3.36M | 1,731,119 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-09-07 | 2021-09-09 | 625,000 | $9.70 | $6.06M | 1,989,575 | SEC↗ |
| RLYB Rallybio Corp | P Buy | 2021-08-02 | 2021-08-04 | 615,384 | $13.00 | $8.00M | 1,406,098 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 5,876,034 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 13,233,885 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 8,845,942 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 8,201,930 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion deriv | 2021-04-27 | 2021-04-29 | 1,359,799 | — | $0 | 0 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 358,878 | — | $0 | 2,208,334 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | P Buy | 2021-04-27 | 2021-04-29 | 575,000 | $15.00 | $8.63M | 575,000 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 101,457 | $13.50 | $1.37M | 2,309,791 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 500,932 | — | $0 | 1,849,456 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 540,265 | — | $0 | 1,348,524 | SEC↗ |
| IMPL IMPEL NEUROPHARMA INC | C Conversion | 2021-04-27 | 2021-04-29 | 808,259 | — | $0 | 808,259 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 19,230,768 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 19,230,768 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion deriv | 2021-02-09 | 2021-02-09 | 45,000,000 | — | $0 | 0 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 3,308,822 | — | $0 | 3,308,822 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,414,026 | — | $0 | 4,722,848 | SEC↗ |
| VOR Vor Biopharma Inc. | C Conversion | 2021-02-09 | 2021-02-09 | 1,414,026 | — | $0 | 1,414,026 | SEC↗ |
| VOR Vor Biopharma Inc. | P Buy | 2021-02-09 | 2021-02-09 | 444,444 | $18.00 | $8.00M | 1,858,470 | SEC↗ |
| VOR Vor Biopharma Inc. | P Buy | 2021-02-09 | 2021-02-09 | 111,111 | $18.00 | $2.00M | 4,833,959 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-01-12 | 2021-01-12 | 74,470 | $13.00 | $968.1K | 2,614,575 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-01-12 | 2021-01-12 | 10,530 | $13.00 | $136.9K | 369,688 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-01-08 | 2021-01-12 | 37,411 | $13.00 | $486.3K | 380,218 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2021-01-08 | 2021-01-12 | 264,589 | $13.00 | $3.44M | 2,689,045 | SEC↗ |
| AKUS Akouos, Inc. | S Sale | 2020-12-29 | 2020-12-31 | 358,352 | $18.00 | $6.45M | 3,153,331 | SEC↗ |
| AKUS Akouos, Inc. | S Sale | 2020-12-29 | 2020-12-31 | 111,648 | $18.00 | $2.01M | 982,453 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2020-12-10 | 2020-12-14 | 36,916 | $14.75 | $544.5K | 417,629 | SEC↗ |
| CABA Cabaletta Bio, Inc. | S Sale | 2020-12-10 | 2020-12-14 | 261,084 | $14.75 | $3.85M | 2,953,634 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | S Sale | 2020-11-11 | 2020-11-13 | 657,117 | $13.66 | $8.98M | 2,187,428 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | S Sale | 2020-11-11 | 2020-11-13 | 115,504 | $13.66 | $1.58M | 384,496 | SEC↗ |
| IDYA IDEAYA Biosciences, Inc. | S Sale | 2020-11-11 | 2020-11-13 | 27,379 | $13.66 | $374.0K | 91,142 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-10-05 | 2020-10-07 | 175,000 | $25.30 | $4.43M | 138,497 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 42,102,730 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 21,072,595 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 16,858,076 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-02 | 10,826,417 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 999,980 | — | $0 | 3,511,683 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 799,984 | — | $0 | 799,984 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-02 | 294,117 | $17.00 | $5.00M | 1,094,101 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 1,997,946 | — | $0 | 2,511,703 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-02 | 513,757 | — | $0 | 513,757 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-06-16 | 2020-06-18 | 19,836 | $33.30 | $660.5K | 313,497 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-06-16 | 2020-06-18 | 4,807 | $33.30 | $160.1K | 75,965 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-06-16 | 2020-06-18 | 115,357 | $33.30 | $3.84M | 1,823,192 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-06-11 | 2020-06-15 | 9,800 | $28.75 | $281.8K | 80,772 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-06-11 | 2020-06-15 | 235,200 | $28.75 | $6.76M | 1,938,549 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-05-19 | 2020-05-21 | 10,200 | $35.15 | $358.5K | 90,572 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | S Sale | 2020-05-19 | 2020-05-21 | 244,800 | $35.15 | $8.60M | 2,173,748 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-31 | 1,675,532 | — | $0 | 0 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion deriv | 2019-10-29 | 2019-10-31 | 3,146,551 | — | $0 | 0 | SEC↗ |
| CABA Cabaletta Bio, Inc. | P Buy | 2019-10-29 | 2019-10-31 | 454,545 | $11.00 | $5.00M | 454,545 | SEC↗ |
| CABA Cabaletta Bio, Inc. | C Conversion | 2019-10-29 | 2019-10-31 | 3,214,721 | — | $0 | 3,214,721 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion deriv | 2019-10-07 | 2019-10-09 | 20,519 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion deriv | 2019-10-07 | 2019-10-09 | 492,475 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion deriv | 2019-10-07 | 2019-10-09 | 79,746 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion deriv | 2019-10-07 | 2019-10-09 | 1,913,910 | — | $0 | 0 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion | 2019-10-07 | 2019-10-09 | 20,519 | — | $0 | 100,772 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion | 2019-10-07 | 2019-10-09 | 492,475 | — | $0 | 2,418,548 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion | 2019-10-07 | 2019-10-09 | 79,746 | — | $0 | 80,253 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | C Conversion | 2019-10-07 | 2019-10-09 | 1,913,910 | — | $0 | 1,926,073 | SEC↗ |
| APRE Aprea Therapeutics, Inc. | P Buy | 2019-10-07 | 2019-10-09 | 333,333 | $15.00 | $5.00M | 333,333 | SEC↗ |